Clinical trial
Gemcitabine With or Without Capecitabine in Treating Patients With Advanced…
NCT00030732 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00030732 |
|---|---|
| Title | Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer |
| Official title | Gemcitabine Plus Capecitabine Versus Gemcitabine Alone In Advanced Pancreatic Cancer. A Randomized Phase III Trial |
| Lead sponsor | Swiss Cancer Institute, Other |
| Collaborators | Central European Cooperative Oncology Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine + Capecitabine, Gemcitabine alone |
| Enrollment | 319 |
| Start date | Jun 1, 2001 |
| Primary completion | Jun 1, 2004 |
| Completion | Apr 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | May 15, 2019 |
| Countries | Austria, Israel, Italy, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: